The organised efforts of governments, health systems, and communities to prevent substance-related harms, promote wellbeing, and improve population health outcomes. A public health approach focuses on prevention, early intervention, treatment, recovery support, and harm reduction, while also addressing the social, economic, and environmental factors that influence substance use. It relies on surveillance data, evidence-based interventions, policies, and cross-sector collaboration to reduce the overall burden of substance use disorders and promote healthier communities.
Public Health
New Psychoactive Substances (NPS) Webinar Series
New Psychoactive Substances: What Are Synthetic Cannabinoids, Their Mechanisms of Action, and Health Risks?
Thursday, July 7, 2022 10:00 AM Eastern Time (Washington, DC time)
The presenters will discuss synthetic cannabinoids' action mechanisms and health risks in this webinar. Spanish - English interpretation will be available. No certificates of attendance will be offered.
Presenters
Highlights from the 2022 UNODC World Drug Report: Implications for drug prevention, treatment and care responses
Highlights from the 2022 UNODC World Drug Report: Implications for drug prevention, treatment and care responses
ISSUP presented a webinar on Thursday, July 7, 2014, featuring Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC) presenting highlights from the 2022 edition of the UNODC World Drug Report. The presentation included implications on drug prevention, treatment and rehabilitation responses during times of crisis.
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
New Psychoactive Substances (NPS): Black market and policy of new psychoactive substances in the Asia region
New Psychoactive Substances (NPS): Black market and policy of new psychoactive substances in the Asia region
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances
Risks, harms and clinical implications of Novel Psychoactive Substances
As part for the new webinar series of International Society for the Study of Emerging Drugs (ISSED), we are pleased to invite you to attend a workshop on “Health Risks, Harms and Clinical Implications of Novel Psychoactive Substances” facilitated by Prof. Giuseppe Bersani and Prof. Owen Bowden-Jones.
Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS